Clinica Chimica Acta:新生儿短链和长链酰基辅酶a脱氢酶缺陷患者的筛查和遗传特征

2020-08-09 MedSci原创 MedSci原创

酰基辅酶a脱氢酶缺乏症是一组线粒体脂肪酸氧化疾病,在中国大陆很少报道。本研究评估了通过新生儿筛查发现的短链和极长链酰基辅酶a脱氢酶缺陷(SCADD/VLCADD)患者的生化和遗传特征。

酰基辅酶a脱氢酶缺乏症是一组线粒体脂肪酸氧化疾病,在中国大陆很少报道。本研究评估了通过新生儿筛查发现的短链和极长链酰基辅酶a脱氢酶缺陷(SCADD/VLCADD)患者的生化和遗传特征。利用生信预测和结构模型研究了遗传变异对蛋白质功能的影响。

在364,545例筛查的新生儿中,4例诊断为SCADD, 4例为VLCADD。人群中SCADD和VLCADD的发病率为1:91 136。所有患者显示C4或C14:1水平升高。3例SCADD患者尿乙基丙二酸浓度升高。鉴定出6个ACADS和8个ACADVL变异,没有热点变异,包括4个误义变异和1个剪接位点变异未报道。ACADVL c.1434 + 2 T > C是一种剪接位点变异,可影响剪接,导致14外显子跳跃。在计算机工具中预测错义变体会致病。结构建模证实,错义变体可能影响四级结构,导致蛋白质不稳定。

本研究的发现扩展了ACADS和ACADVL的突变谱。计算机硅预测和结构模型的结合可以提高对未报道的遗传变异的致病性的理解,为变异评估提供一个解释。

原始出处:

YimingLin,Weifeng Zhang,Newborn screening and genetic characteristics of patients with short- and very long-chain acyl-CoA dehydrogenase deficiencies

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663664, encodeId=3e741663664f7, content=<a href='/topic/show?id=355c9518883' target=_blank style='color:#2F92EE;'>#遗传特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95188, encryptionId=355c9518883, topicName=遗传特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6b25658831, createdName=ms3830150583600765, createdTime=Wed Jun 16 10:00:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082853, encodeId=6acc2082853bb, content=<a href='/topic/show?id=62bb93e196b' target=_blank style='color:#2F92EE;'>#辅酶A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93719, encryptionId=62bb93e196b, topicName=辅酶A)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jan 29 00:00:24 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850013, encodeId=668318500134a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Jan 24 22:00:24 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663664, encodeId=3e741663664f7, content=<a href='/topic/show?id=355c9518883' target=_blank style='color:#2F92EE;'>#遗传特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95188, encryptionId=355c9518883, topicName=遗传特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6b25658831, createdName=ms3830150583600765, createdTime=Wed Jun 16 10:00:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082853, encodeId=6acc2082853bb, content=<a href='/topic/show?id=62bb93e196b' target=_blank style='color:#2F92EE;'>#辅酶A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93719, encryptionId=62bb93e196b, topicName=辅酶A)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jan 29 00:00:24 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850013, encodeId=668318500134a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Jan 24 22:00:24 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663664, encodeId=3e741663664f7, content=<a href='/topic/show?id=355c9518883' target=_blank style='color:#2F92EE;'>#遗传特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95188, encryptionId=355c9518883, topicName=遗传特征)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b6b25658831, createdName=ms3830150583600765, createdTime=Wed Jun 16 10:00:24 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082853, encodeId=6acc2082853bb, content=<a href='/topic/show?id=62bb93e196b' target=_blank style='color:#2F92EE;'>#辅酶A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93719, encryptionId=62bb93e196b, topicName=辅酶A)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jan 29 00:00:24 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1850013, encodeId=668318500134a, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sun Jan 24 22:00:24 CST 2021, time=2021-01-24, status=1, ipAttribution=)]
    2021-01-24 windight